"What if…": decisional regret in patients who discontinued active surveillance.

Published on Sep 22, 2016in Tumori1.707
· DOI :10.5301/TJ.5000564
Claudia Repetto17
Estimated H-index: 17
(CUA: The Catholic University of America),
Tiziana Rancati27
Estimated H-index: 27
+ 11 AuthorsLara Bellardita10
Estimated H-index: 10
Sources
Abstract
PurposeTo investigate the presence of regret in patients about having followed an active surveillance (AS) protocol. The secondary aim was to identify variables that influence regret.MethodsFrom February 2006 to May 2014, 204 patients discontinued the AS protocols and were invited to enter the study. Sociodemographic variables were collected at AS enrollment, together with health-related quality of life (Functional Assessment of Cancer Therapy-Prostate version [FACT-P]) and coping (Mini-Mental Adjustment to Cancer). Patients were asked to complete a Treatment Regret Scale as well as the FACT-P questionnaire. Clinical data were gathered, as well as time of stay within the AS protocol, reason for discontinuing AS, kind of post-AS treatment, and time elapsed since AS discontinuation. Questionnaires were completed by 105 patients (51.5% of those who had been invited to enter the study).ResultsMost of the patients had a low or null degree of regret on the Treatment Regret Scale from 0 to 100 (82/105 patients [...
📖 Papers frequently viewed together
9 Citations
28 Citations
References21
Newest
#1Julia J. van Tol-Geerdink (Radboud University Nijmegen)H-Index: 9
#2Jan Willem H. Leer (Radboud University Nijmegen)H-Index: 43
Last. Peep F. M. Stalmeier (Radboud University Nijmegen)H-Index: 31
view all 8 authors...
Objective To develop and validate new regret scales and examine whether a decision aid affects different aspects of regret in the treatment choice for prostate cancer. Methods This was a multicentre trial (three sites) with imbalanced randomization (1 : 2). From 2008 to 2011, patients with localized prostate cancer were randomized 1 : 2 to usual care (N = 77) or usual care plus a decision aid presenting risks and benefits of different treatments (N = 163). The treatments were surgery and (extern...
28 CitationsSource
#1David ChristieH-Index: 29
#2Christopher F. Sharpley (UNE: University of New England (Australia))H-Index: 34
Last. Vicki Bitsika (Bond University)H-Index: 19
view all 3 authors...
Objective The aim of this study was to review regret following treatment for localized prostate cancer, including factors associated with higher levels of regret, regret after specific treatments and the use of interventions to modify the likelihood of regret. Methods Online databases including Medline, CINAHL, EMBASE, EBSCO and PsycINFO were searched in June 2014, using the terms ‘prostate’ and ‘regret’ for publications written in English and appearing in print since the year 1997. Results Of 4...
46 CitationsSource
#1Bonny B. Morris (Baptist Memorial Hospital-Memphis)H-Index: 1
#2Laura FarnanH-Index: 8
Last. Jeannette T. BensenH-Index: 29
view all 9 authors...
BACKGROUND It has been demonstrated that treatment decisional regret affects quality of life in patients with prostate cancer (CaP); however, there are limited studies that identify factors associated with treatment decisional regret, particularly within a racially diverse patient population that has extended follow-up. METHODS Logistic regression analysis was used to determine associations between decisional regret and potential predictors in a population-based cohort of 348 African American me...
23 CitationsSource
#1Lara BellarditaH-Index: 10
#2Riccardo ValdagniH-Index: 51
Last. Ida J. Korfage (Erasmus University Medical Center)H-Index: 36
view all 8 authors...
Abstract Context The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer. Objective To systematically review the literature on quality of life (QoL) in patients undergoing AS. Evidence acquisition Embase, Medline, Psychinfo, ...
87 CitationsSource
#1Padraig WardeH-Index: 79
#2Malcolm David Mason (Cardiff University)H-Index: 91
Last. Wendy R. ParulekarH-Index: 33
view all 19 authors...
Summary Background Whether the addition of radiation therapy (RT) improves overall survival in men with locally advanced prostate cancer managed with androgen deprivation therapy (ADT) is unclear. Our aim was to compare outcomes in such patients with locally advanced prostate cancer. Methods Patients with: locally advanced (T3 or T4) prostate cancer (n=1057); or organ-confined disease (T2) with either a prostate-specific antigen (PSA) concentration more than 40 ng/mL (n=119) or PSA concentration...
406 CitationsSource
#1Matthew R. Cooperberg (UCSF: University of California, San Francisco)H-Index: 74
#2Peter R. CarrollH-Index: 141
Last. Laurence KlotzH-Index: 85
view all 3 authors...
Widespread prostate-specific antigen (PSA) –based screening and aggressive treatment of prostate cancer have reduced mortality rates substantially, but both remain controversial in large part because of high rates of overdiagnosis and overtreatment of otherwise indolent tumors. Active surveillance—or close monitoring of PSA levels combined with periodic imaging and repeat biopsies—is gaining acceptance as an alternative initial management strategy for men with low-risk prostate cancer. In report...
240 CitationsSource
#1Yu-Hua Lin (ISU: I-Shou University)H-Index: 12
Background: Issues such as physical and psychological distress impact the quality of life of patients after a radical prostatectomy (RP). It is important to understand the regret that patients often report following a RP and the factors that influence their regret. Objective: The objective of the present study was to understand the regret that patients report following a RP and the influencing factors for their regret. Methods: Patients who had a diagnosis of prostate cancer and who underwent a ...
28 CitationsSource
#1Louis DenisH-Index: 21
#2Monique J. Roobol (EUR: Erasmus University Rotterdam)H-Index: 76
view all 3 authors...
AbstractThe democratization of civil society and the development of modern medicine changed the sacrosanct doctor-patient relationship to a doctor-partner dialogue. Values and respect were lost in the process where common courtesy and empathy in trust were replaced by patient rights. Launch of Europa Uomo. Europa Uomo, the European prostate cancer coalition, represents 22 national, autonomous patient support groups. Its aim includes increasing the awareness of prostate diseases, support individu...
17 CitationsSource
#1Scott E. Eggener (U of C: University of Chicago)H-Index: 71
#2Peter T. Scardino (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 159
Last. Andrew J. Stephenson (Cleveland Clinic)H-Index: 57
view all 15 authors...
Purpose: Long-term prostate cancer specific mortality after radical prostatectomy is poorly defined in the era of widespread screening. An understanding of the treated natural history of screen detected cancers and the pathological risk factors for prostate cancer specific mortality are needed for treatment decision making.Materials and Methods: Using Fine and Gray competing risk regression analysis we modeled clinical and pathological data, and followup information on 11,521 patients treated wi...
445 CitationsSource
This issue includes the latest version of the NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer, as well as several articles that clarify and expand on themes in those guidelines. For example, the excellent manuscript from Lee and Amling provides the basis for updating the best available nomograms in the 2010 version of the NCCN Guidelines to help provide more individualized recommendations. This need for individualization includes both choice of treatment (active surveillance vs....
424 CitationsSource
Cited By3
Newest
#1Robert T. Aarhus (GMU: George Mason University)H-Index: 1
#2Edward Huang (GMU: George Mason University)H-Index: 12
Abstract Objectives To perform a systematic review of decision regret studies in cancer patients to determine if regret is longitudinally stable, and whether these study structures account for late-emerging treatment effects. Methods Online databases including the George Mason Libraries, Global Health, Nursing and Allied Health, and PubMed were searched to identify decision regret studies with longitudinal components in patients with cancer. Results A total of 845 unique citations were identifie...
Source
#2Claudia RepettoH-Index: 17
Last. Lara BellarditaH-Index: 10
view all 12 authors...
Purpose:The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) is a self-report questionnaire that was developed in English to assess prostate cancer (PCa)-related anxiety. The aim of this study w...
3 CitationsSource
#1C. MarenghiH-Index: 6
Last. Riccardo Valdagni (University of Milan)H-Index: 51
view all 34 authors...
PurposeTo evaluate the outcomes of active surveillance (AS) on patients with low-risk prostate cancer (PCa) and to identify predictors of disease reclassification.MethodsIn 2005, we defined an inst...
9 CitationsSource